Home | All results_reference

[RDF data]
Results Reference #1367

Resource URI: http://static.linkedct.org/resource/results_reference/1367
linkedct:citation Pegram M, Forbes J, Pienkowski T, et al.: BCIRG 007: first overall survival analysis of randomized phase III trial of trastuzumab plus docetaxel with or without carboplatin as first line therapy in HER2 amplified metastatic breast cancer (MBC). [Abstract] J Clin Oncol 25 (Suppl 18): A-LBA1008, 2007.
rdfs:label Results Reference #1367
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00047255>
linkedct:results_reference_id 1367 (xsd:int)
rdf:type linkedct:results_reference